Uso da hidrocortisona no tratamento e na prevenção da cefaléia pós-punção da dura-máter: relato de casos

Neves, José Francisco Nunes Pereira das; Vieira, Vinícius La Rocca; Saldanha, Rodrigo Machado; Vieira, Francisco de Assis Duarte; Neto, Michele Coutinho; Magalhães, Marcos Gonçalves; Neves, Mariana Moraes Pereira das; Araújo, Fernando Paiva

doi:10.1590/s0034-70942005000300011

Cited by 17 publications

(4 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[7] In patients with severe PDPH after cesarean section received 100 mg hydrocortisone IV 8 hourly for 3 days, in addition to the conventional therapy, headache disappeared completely 12 h after the last dose. [8] The technique of anesthesia and needle gauge was not the same in these patients. Ashraf et al .…”

Section: Discussionmentioning

confidence: 99%

Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache

Alam

Rahman

Ershad

2012

J Anaesthesiol Clin Pharmacol

View full text Add to dashboard Cite

Objective:Headache is not an uncommon complication of spinal anesthesia. The efficacy of intravenous (IV) hydrocortisone in treating the patients with postdural puncture headache was observed in this study.Materials and Methods:Sixty patients with headache following spinal anesthesia were randomly allocated into two groups. Thirty patients received only conventional therapy (recumbent positioning, IV or oral hydration, analgesics with caffeine, stool softeners, and soft diet) plus 2 ml of normal saline IV (placebo) 8 hourly for 48 h. Thirty other patients received conventional therapy plus hydrocortisone IV (100 mg in 2 ml 8 hourly for 48 h). Headache intensity was measured using visual analogue scale.Results:No significant difference was observed in baseline headache intensity between the two groups (P = 0.6642) before beginning of treatment. After 6 h, the mean headache intensity in patients treated conventionally was 6.02 ± 2.46, while it was 2.06 ± 1.98 in other patients who received additional hydrocortisone IV (P < 0.0001). After 24 h, headache intensity was 3.77 ± 1.85 in conventionally treated group versus 0.94 ± 2.67 in hydrocortisone group (P < 0.0001), while it was 1.95 ± 1.12 in conventionally treated group versus 0.69 ± 1.64 in hydrocortisone group (P = 0.001) after 48 h.Conclusions:Very short-term use of IV hydrocortisone was found effective in reducing headache following spinal anesthesia. However, its clear mechanism of action is yet to be determined. Large-scale studies are recommended to consider the steroid therapy as a standard treatment for postdural puncture headache.

show abstract

Section: Discussionmentioning

confidence: 99%

Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache

Alam

Rahman

Ershad

2012

J Anaesthesiol Clin Pharmacol

View full text Add to dashboard Cite

show abstract

“…Some workers have used injectables corticosteroids for the management of PDPH prophylactically as well as therapeutically. [ 8 9 12 15 ] Alam et al . used intravenous hydrocortisone 100 mg thrice daily for 3 days in patients who developed PDPH after spinal anesthesia and found that hydrocortisone was effective in reducing headache.…”

Section: Discussionmentioning

confidence: 99%

“…Few researchers have also used corticosteroids for the management of PDPH. [ 8 9 ] PDPH resistant to all medical therapies is treated with invasive techniques such as autologous epidural blood patch. [ 2 ]…”

Section: Introductionmentioning

confidence: 99%

Role of oral prednisolone in the management of postdural puncture headache after spinal anesthesia in urological patients

et al. 2017

View full text Add to dashboard Cite

Background and Aims:Postdural puncture headache (PDPH) is a frequently encountered complication of spinal anesthesia and may be associated with significant morbidity in some patients. Parenteral corticosteroids have been used in the management of PDPH both prophylactically and after the occurrence of headache. The aim of this study was to evaluate the effect of oral prednisolone in the management of PDPH after spinal anesthesia in urological patients.Materials and Methods:Sixty adult patients who developed PDPH after spinal anesthesia for urological surgeries were randomly allocated to two groups. Group C patients (n = 30) were managed conservatively, and Group P patients (n = 30) were given 20 mg of oral prednisolone for 4 days in addition to the conventional treatment. The intensity of headache was measured using visual analog scale (VAS). VAS score was taken just before the start of treatment (0 h) and at 12, 24, 48, 72, and 96 h after the start of treatment.Statistical Analysis:Statistical analysis was performed using Statistical Packages for Social Science version 19 (SPSS, Inc., Chicago, IL, USA).Results:There was no statistically significant difference in the VAS score in patients before the start of treatment (0 h) and at 12 h after the start of treatment. The VAS scores were less and statistically significant in Group P at 24, 48, 72 and 96 h after the start of treatment (P < 0.05).Conclusion:The use of oral prednisolone is effective in reducing the severity and duration of PDPH.

show abstract

“…Quanto ao tratamento, Neves (2005) ressalta que os casos leves e moderados respondem bem ao tratamento conservador à base de repouso, hidratação, analgésicos e cafeína. Porém os casos que não respondem a este tratamento acabam por maior tempo de internação hospitalar.…”

Section: Causas X Tratamentounclassified

Complicações Da Implantação De Marca- Passo Em Pacientes Diabéticos

Cavalcanti¹,

Souza²,

Bomfim³

et al. 2022

Serviços E Cuidados Nas Ciências Da Saúde

View full text Add to dashboard Cite

Direitos para esta edição cedidos à Atena Editora pelos autores. Open access publication by Atena Editora Todo o conteúdo deste livro está licenciado sob uma Licença de Atribuição Creative Commons. Atribuição-Não-Comercial-NãoDerivativos 4.0 Internacional (CC BY-NC-ND 4.0). O conteúdo dos artigos e seus dados em sua forma, correção e confiabilidade são de responsabilidade exclusiva dos autores, inclusive não representam necessariamente a posição oficial da Atena Editora. Permitido o download da obra e o compartilhamento desde que sejam atribuídos créditos aos autores, mas sem a possibilidade de alterá-la de nenhuma forma ou utilizá-la para fins comerciais.Todos os manuscritos foram previamente submetidos à avaliação cega pelos pares, membros do Conselho Editorial desta Editora, tendo sido aprovados para a publicação com base em critérios de neutralidade e imparcialidade acadêmica.A Atena Editora é comprometida em garantir a integridade editorial em todas as etapas do processo de publicação, evitando plágio, dados ou resultados fraudulentos e impedindo que interesses financeiros comprometam os padrões éticos da publicação. Situações suspeitas de má conduta científica serão investigadas sob o mais alto padrão de rigor acadêmico e ético.

show abstract

Uso da hidrocortisona no tratamento e na prevenção da cefaléia pós-punção da dura-máter: relato de casos

Abstract: RESUMONeves JFNP, Vieira VLR, Saldanha RM, Vieira FAD, Coutinho Neto M, Magalhães MG, Neves MMP, Araujo FP -Uso da Hidrocortisona no Tratamento e na Prevenção da Cefaléia Pós-Punção da Dura-Máter. Relato

Cited by 17 publications

References 1 publication

Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache

Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache

Role of oral prednisolone in the management of postdural puncture headache after spinal anesthesia in urological patients

Complicações Da Implantação De Marca- Passo Em Pacientes Diabéticos

Contact Info

Product

Resources

About